Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 271

1.

Increasing the sensitivity of the human microvesicle tissue factor activity assay.

Vallier L, Bouriche T, Bonifay A, Judicone C, Bez J, Franco C, Guervilly C, Hisada Y, Mackman N, Houston R, Poncelet P, Dignat-George F, Lacroix R.

Thromb Res. 2019 Oct;182:64-74. doi: 10.1016/j.thromres.2019.07.011. Epub 2019 Jul 19.

PMID:
31450010
2.

Microvesicles and Cancer Associated Thrombosis.

Lacroix R, Vallier L, Bonifay A, Simoncini S, Mege D, Aubert M, Panicot-Dubois L, Dubois C, Dignat-George F.

Semin Thromb Hemost. 2019 Sep;45(6):593-603. doi: 10.1055/s-0039-1693476. Epub 2019 Aug 20.

PMID:
31430786
3.

Platelets, Thrombo-Inflammation, and Cancer: Collaborating With the Enemy.

Palacios-Acedo AL, Mège D, Crescence L, Dignat-George F, Dubois C, Panicot-Dubois L.

Front Immunol. 2019 Jul 31;10:1805. doi: 10.3389/fimmu.2019.01805. eCollection 2019. Review.

4.

Involvement of Platelets in Cancers.

Mege D, Aubert M, Lacroix R, Dignat-George F, Panicot-Dubois L, Dubois C.

Semin Thromb Hemost. 2019 Sep;45(6):569-575. doi: 10.1055/s-0039-1693475. Epub 2019 Aug 5.

PMID:
31382305
5.

Extracellular vesicles from T cells overexpress miR-146b-5p in HIV-1 infection and repress endothelial activation.

Balducci E, Leroyer AS, Lacroix R, Robert S, Todorova D, Simoncini S, Lyonnet L, Chareyre C, Zaegel-Faucher O, Micallef J, Poizot-Martin I, Roll P, Dignat-George F.

Sci Rep. 2019 Jul 16;9(1):10299. doi: 10.1038/s41598-019-44743-w.

6.

FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients' Survival After Lung Transplant.

Paul P, Pedini P, Lyonnet L, Di Cristofaro J, Loundou A, Pelardy M, Basire A, Dignat-George F, Chiaroni J, Thomas P, Reynaud-Gaubert M, Picard C.

Front Immunol. 2019 Jun 12;10:1208. doi: 10.3389/fimmu.2019.01208. eCollection 2019.

7.

Toward standardization of assays measuring extracellular vesicle-associated tissue factor activity.

Nieuwland R, Gardiner C, Dignat-George F, Mullier F, Mackman N, Woodhams B, Thaler J.

J Thromb Haemost. 2019 Aug;17(8):1261-1264. doi: 10.1111/jth.14481. Epub 2019 Jun 23. No abstract available.

PMID:
31231949
8.

Thrombosis Risk Associated with Head and Neck Cancer: A Review.

Haen P, Mege D, Crescence L, Dignat-George F, Dubois C, Panicot-Dubois L.

Int J Mol Sci. 2019 Jun 11;20(11). pii: E2838. doi: 10.3390/ijms20112838. Review.

9.

CD146 (Cluster of Differentiation 146).

Leroyer AS, Blin MG, Bachelier R, Bardin N, Blot-Chabaud M, Dignat-George F.

Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1026-1033. doi: 10.1161/ATVBAHA.119.312653.

PMID:
31070478
10.

Response to: 'Could autologous adipose-derived stromal vascular fraction turn out an unwanted source of profibrotic myofibroblasts in systemic sclerosis?' by Manetti.

Velier M, Magalon J, Simoncini S, Dignat-George F, Granel B, Paul P, Sabatier F.

Ann Rheum Dis. 2019 Apr 9. pii: annrheumdis-2019-215327. doi: 10.1136/annrheumdis-2019-215327. [Epub ahead of print] No abstract available.

PMID:
30967396
11.

Neutrophil extracellular traps are associated with the pathogenesis of diffuse alveolar hemorrhage in murine lupus.

Jarrot PA, Tellier E, Plantureux L, Crescence L, Robert S, Chareyre C, Daniel L, Secq V, Garcia S, Dignat-George F, Panicot-Dubois L, Dubois C, Kaplanski G.

J Autoimmun. 2019 Jun;100:120-130. doi: 10.1016/j.jaut.2019.03.009. Epub 2019 Mar 28.

PMID:
30930069
12.

CD146 deficiency promotes plaque formation in a mouse model of atherosclerosis by enhancing RANTES secretion and leukocyte recruitment.

Blin MG, Bachelier R, Fallague K, Moussouni K, Aurrand-Lions M, Fernandez S, Guillet B, Robert S, Foucault-Bertaud A, Bardin N, Blot-Chabaud M, Dignat-George F, Leroyer AS.

J Mol Cell Cardiol. 2019 May;130:76-87. doi: 10.1016/j.yjmcc.2019.03.017. Epub 2019 Mar 27.

PMID:
30928429
13.

Response to: 'Adipose stromal vascular fraction and regenerative therapy in SSc: response to the article by Magalon et al' by De Benedetto et al.

Magalon J, Velier M, Simoncini S, Dignat-George F, Granel B, Paul P, Sabatier F.

Ann Rheum Dis. 2019 Feb 20. pii: annrheumdis-2019-215132. doi: 10.1136/annrheumdis-2019-215132. [Epub ahead of print] No abstract available.

PMID:
30787004
14.

Molecular profile and proangiogenic activity of the adipose-derived stromal vascular fraction used as an autologous innovative medicinal product in patients with systemic sclerosis.

Magalon J, Velier M, Simoncini S, François P, Bertrand B, Daumas A, Benyamine A, Boissier R, Arnaud L, Lyonnet L, Fernandez S, Dignat-George F, Casanova D, Guillet B, Granel B, Paul P, Sabatier F.

Ann Rheum Dis. 2019 Mar;78(3):391-398. doi: 10.1136/annrheumdis-2018-214218. Epub 2019 Jan 5.

PMID:
30612118
15.

Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction.

Gasecka A, Nieuwland R, Budnik M, Dignat-George F, Eyileten C, Harrison P, Huczek Z, Kapłon-Cieślicka A, Lacroix R, Opolski G, Pluta K, van der Pol E, Postuła M, Leroyer A, Siljander P, Sturk A, Filipiak KJ.

Platelets. 2018 Dec 26:1-7. doi: 10.1080/09537104.2018.1557616. [Epub ahead of print]

PMID:
30585111
16.

Use of platelet-rich plasma in regenerative medicine: technical tools for correct quality control.

Graiet H, Lokchine A, Francois P, Velier M, Grimaud F, Loyens M, Berda-Haddad Y, Veran J, Dignat-George F, Sabatier F, Magalon J.

BMJ Open Sport Exerc Med. 2018 Nov 13;4(1):e000442. doi: 10.1136/bmjsem-2018-000442. eCollection 2018.

17.

Impacts of Cancer on Platelet Production, Activation and Education and Mechanisms of Cancer-Associated Thrombosis.

Plantureux L, Mège D, Crescence L, Dignat-George F, Dubois C, Panicot-Dubois L.

Cancers (Basel). 2018 Nov 14;10(11). pii: E441. doi: 10.3390/cancers10110441. Review.

18.

Early prediction of revascularisation by angiomotin-targeting positron emission tomography.

Moyon A, Garrigue P, Balasse L, Fernandez S, Brige P, Nollet M, Hache G, Blot-Chabaud M, Dignat-George F, Guillet B.

Theranostics. 2018 Oct 5;8(18):4985-4994. doi: 10.7150/thno.27728. eCollection 2018.

19.

Mechanisms of tissue factor induction by the uremic toxin indole-3 acetic acid through aryl hydrocarbon receptor/nuclear factor-kappa B signaling pathway in human endothelial cells.

Addi T, Poitevin S, McKay N, El Mecherfi KE, Kheroua O, Jourde-Chiche N, de Macedo A, Gondouin B, Cerini C, Brunet P, Dignat-George F, Burtey S, Dou L.

Arch Toxicol. 2019 Jan;93(1):121-136. doi: 10.1007/s00204-018-2328-3. Epub 2018 Oct 15.

PMID:
30324315
20.

Sepsis is associated with lack of monocyte HLA-DR expression recovery without modulating T-cell reconstitution after lung transplantation.

Alingrin J, Coiffard B, Textoris J, Nicolino-Brunet C, Gossez M, Jarrot PA, Dignat-George F, Monneret G, Thomas PA, Leone M, Reynaud-Gaubert M, Papazian L.

Transpl Immunol. 2018 Dec;51:6-11. doi: 10.1016/j.trim.2018.08.001. Epub 2018 Aug 3.

PMID:
30081187
21.

Circadian Rhythm Disruption and Sepsis in Severe Trauma Patients.

Coiffard B, Diallo AB, Culver A, Mezouar S, Hammad E, Vigne C, Nicolino-Brunet C, Dignat-George F, Baumstarck K, Boucekine M, Leone M, Mege JL.

Shock. 2019 Jul;52(1):29-36. doi: 10.1097/SHK.0000000000001241.

PMID:
30074979
22.

Natural Killer Cells Exhibit a Peculiar Phenotypic Profile in Systemic Sclerosis and Are Potent Inducers of Endothelial Microparticles Release.

Benyamine A, Magalon J, Sabatier F, Lyonnet L, Robert S, Dumoulin C, Morange S, Mazodier K, Kaplanski G, Reynaud-Gaubert M, Rossi P, Dignat-George F, Granel B, Paul P.

Front Immunol. 2018 Jul 18;9:1665. doi: 10.3389/fimmu.2018.01665. eCollection 2018.

23.

A new assay to evaluate microvesicle plasmin generation capacity: validation in disease with fibrinolysis imbalance.

Cointe S, Harti Souab K, Bouriche T, Vallier L, Bonifay A, Judicone C, Robert S, Armand R, Poncelet P, Albanese J, Dignat-George F, Lacroix R.

J Extracell Vesicles. 2018 Jul 16;7(1):1494482. doi: 10.1080/20013078.2018.1494482. eCollection 2018.

24.

Stem cell properties of peripheral blood endothelial progenitors are stimulated by soluble CD146 via miR-21: potential use in autologous cell therapy.

Essaadi A, Nollet M, Moyon A, Stalin J, Simoncini S, Balasse L, Bertaud A, Bachelier R, Leroyer AS, Sarlon G, Guillet B, Dignat-George F, Bardin N, Blot-Chabaud M.

Sci Rep. 2018 Jun 20;8(1):9387. doi: 10.1038/s41598-018-27715-4.

25.

Arginase upregulation and eNOS uncoupling contribute to impaired endothelium-dependent vasodilation in a rat model of intrauterine growth restriction.

Grandvuillemin I, Buffat C, Boubred F, Lamy E, Fromonot J, Charpiot P, Simoncini S, Sabatier F, Dignat-George F, Peyter AC, Simeoni U, Yzydorczyk C.

Am J Physiol Regul Integr Comp Physiol. 2018 Sep 1;315(3):R509-R520. doi: 10.1152/ajpregu.00354.2017. Epub 2018 May 9.

26.

Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma.

Dufies M, Nollet M, Ambrosetti D, Traboulsi W, Viotti J, Borchiellini D, Grépin R, Parola J, Giuliano S, Helley-Russick D, Bensalah K, Ravaud A, Bernhard JC, Schiappa R, Bardin N, Dignat-George F, Rioux-Leclercq N, Oudard S, Négrier S, Ferrero JM, Chamorey E, Blot-Chabaud M, Pagès G.

Theranostics. 2018 Mar 28;8(9):2447-2458. doi: 10.7150/thno.23002. eCollection 2018.

27.

Effects of platelets on cancer progression.

Plantureux L, Crescence L, Dignat-George F, Panicot-Dubois L, Dubois C.

Thromb Res. 2018 Apr;164 Suppl 1:S40-S47. doi: 10.1016/j.thromres.2018.01.035. Review.

PMID:
29703484
28.

Cancer risk in HIV-infected patients: elite controllers are also concerned.

Poizot-Martin I, Laroche H, Cano CE, Nicolino-Brunet C, Zaegel-Faucher O, Bregigeon S, Tamalet C, Dignat-George F.

AIDS. 2018 Mar 13;32(5):673-675. doi: 10.1097/QAD.0000000000001736. No abstract available.

PMID:
29494425
29.

Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease.

Dou L, Poitevin S, Sallée M, Addi T, Gondouin B, McKay N, Denison MS, Jourde-Chiche N, Duval-Sabatier A, Cerini C, Brunet P, Dignat-George F, Burtey S.

Kidney Int. 2018 Apr;93(4):986-999. doi: 10.1016/j.kint.2017.11.010. Epub 2018 Feb 1.

PMID:
29395338
30.

A novel anti-CD146 antibody specifically targets cancer cells by internalizing the molecule.

Nollet M, Stalin J, Moyon A, Traboulsi W, Essaadi A, Robert S, Malissen N, Bachelier R, Daniel L, Foucault-Bertaud A, Gaudy-Marqueste C, Lacroix R, Leroyer AS, Guillet B, Bardin N, Dignat-George F, Blot-Chabaud M.

Oncotarget. 2017 Nov 28;8(68):112283-112296. doi: 10.18632/oncotarget.22736. eCollection 2017 Dec 22.

31.

Effect of Immunosuppression on Target Blood Immune Cells Within 1 Year After Lung Transplantation: Influence of Age on T Lymphocytes.

Coiffard B, Pelardy M, Loundou AD, Nicolino-Brunet C, Thomas PA, Papazian L, Dignat-George F, Reynaud-Gaubert M.

Ann Transplant. 2018 Jan 5;23:11-24.

32.

Fibrin-bearing microparticles: marker of thrombo-embolic events in pancreatic and colorectal cancers.

Mege D, Crescence L, Ouaissi M, Sielezneff I, Guieu R, Dignat-George F, Dubois C, Panicot-Dubois L.

Oncotarget. 2017 Oct 26;8(57):97394-97406. doi: 10.18632/oncotarget.22128. eCollection 2017 Nov 14.

33.

Indoxyl Sulfate Upregulates Liver P-Glycoprotein Expression and Activity through Aryl Hydrocarbon Receptor Signaling.

Santana Machado T, Poitevin S, Paul P, McKay N, Jourde-Chiche N, Legris T, Mouly-Bandini A, Dignat-George F, Brunet P, Masereeuw R, Burtey S, Cerini C.

J Am Soc Nephrol. 2018 Mar;29(3):906-918. doi: 10.1681/ASN.2017030361. Epub 2017 Dec 8.

34.

Antithrombotic efficacy of bivalirudin compared to unfractionated heparin during percutaneous coronary intervention for acute coronary syndrome.

Frere C, Laine M, Lemesle G, Morange PE, Paganelli F, Dignat-George F, Resseguier N, Guieu R, Camoin-Jau L, Bonello L.

Platelets. 2019;30(1):105-111. doi: 10.1080/09537104.2017.1384541. Epub 2017 Nov 27.

PMID:
29172822
35.

Therapeutic and Diagnostic Antibodies to CD146: Thirty Years of Research on Its Potential for Detection and Treatment of Tumors.

Stalin J, Nollet M, Dignat-George F, Bardin N, Blot-Chabaud M.

Antibodies (Basel). 2017 Nov 5;6(4). pii: E17. doi: 10.3390/antib6040017. Review.

36.

Genetic and Functional Profiling of CD16-Dependent Natural Killer Activation Identifies Patients at Higher Risk of Cardiac Allograft Vasculopathy.

Paul P, Picard C, Sampol E, Lyonnet L, Di Cristofaro J, Paul-Delvaux L, Lano G, Nicolino-Brunet C, Ravis E, Collart F, Dignat-George F, Dussol B, Sabatier F, Mouly-Bandini A.

Circulation. 2018 Mar 6;137(10):1049-1059. doi: 10.1161/CIRCULATIONAHA.117.030435. Epub 2017 Nov 2.

PMID:
29097449
37.

Gestational age-related patterns of AMOT methylation are revealed in preterm infant endothelial progenitors.

Vinci G, Buffat C, Simoncini S, Boubred F, Ligi I, Dumont F, Le Bonniec B, Fournier T, Vaiman D, Dignat-George F, Simeoni U.

PLoS One. 2017 Oct 16;12(10):e0186321. doi: 10.1371/journal.pone.0186321. eCollection 2017.

38.

Long-Term Recovery After Endothelial Colony-Forming Cells or Human Umbilical Cord Blood Cells Administration in a Rat Model of Neonatal Hypoxic-Ischemic Encephalopathy.

Grandvuillemin I, Garrigue P, Ramdani A, Boubred F, Simeoni U, Dignat-George F, Sabatier F, Guillet B.

Stem Cells Transl Med. 2017 Nov;6(11):1987-1996. doi: 10.1002/sctm.17-0074. Epub 2017 Oct 5.

39.

Biogenesis of Pro-senescent Microparticles by Endothelial Colony Forming Cells from Premature Neonates is driven by SIRT1-Dependent Epigenetic Regulation of MKK6.

Simoncini S, Chateau AL, Robert S, Todorova D, Yzydorzick C, Lacroix R, Ligi I, Louis L, Bachelier R, Simeoni U, Magdinier F, Dignat-George F, Sabatier F.

Sci Rep. 2017 Aug 15;7(1):8277. doi: 10.1038/s41598-017-08883-1.

40.

Platelet function and microparticle levels in atrial fibrillation: Changes during the acute episode.

Pourtau L, Sellal JM, Lacroix R, Poncelet P, Bernus O, Clofent-Sanchez G, Hocini M, Haïssaguerre M, Dignat-George F, Sacher F, Nurden P.

Int J Cardiol. 2017 Sep 15;243:216-222. doi: 10.1016/j.ijcard.2017.03.068.

41.

Acetylsalicylic acid differentially limits the activation and expression of cell death markers in human platelets exposed to Staphylococcus aureus strains.

Chabert A, Damien P, Verhoeven PO, Grattard F, Berthelot P, Zeni F, Panicot-Dubois L, Robert S, Dignat-George F, Eyraud MA, Pozzetto B, Payrastre B, Cognasse F, Garraud O, Hamzeh-Cognasse H.

Sci Rep. 2017 Jul 17;7(1):5610. doi: 10.1038/s41598-017-06024-2.

42.

The Evolving Role of Succinate in Tumor Metabolism: An 18F-FDG-Based Study.

Garrigue P, Bodin-Hullin A, Balasse L, Fernandez S, Essamet W, Dignat-George F, Pacak K, Guillet B, Taïeb D.

J Nucl Med. 2017 Nov;58(11):1749-1755. doi: 10.2967/jnumed.117.192674. Epub 2017 Jun 15.

43.

Identification of CD146 as a novel molecular actor involved in systemic sclerosis.

Kaspi E, Heim X, Granel B, Guillet B, Stalin J, Nollet M, Bertaud-Foucault A, Robaglia-Schlupp A, Roll P, Cau P, Leroyer A, Bachelier R, Benyamine A, Dignat-George F, Blot-Chabaud M, Bardin N.

J Allergy Clin Immunol. 2017 Nov;140(5):1448-1451.e6. doi: 10.1016/j.jaci.2017.04.046. Epub 2017 Jun 9. No abstract available.

PMID:
28606586
44.

Microvesicles in vascular homeostasis and diseases. Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology.

Ridger VC, Boulanger CM, Angelillo-Scherrer A, Badimon L, Blanc-Brude O, Bochaton-Piallat ML, Boilard E, Buzas EI, Caporali A, Dignat-George F, Evans PC, Lacroix R, Lutgens E, Ketelhuth DFJ, Nieuwland R, Toti F, Tunon J, Weber C, Hoefer IE.

Thromb Haemost. 2017 Jun 28;117(7):1296-1316. doi: 10.1160/TH16-12-0943. Epub 2017 Jun 1. Review.

45.

Extracellular Vesicles in Angiogenesis.

Todorova D, Simoncini S, Lacroix R, Sabatier F, Dignat-George F.

Circ Res. 2017 May 12;120(10):1658-1673. doi: 10.1161/CIRCRESAHA.117.309681. Review.

46.

Methodological Guidelines to Study Extracellular Vesicles.

Coumans FAW, Brisson AR, Buzas EI, Dignat-George F, Drees EEE, El-Andaloussi S, Emanueli C, Gasecka A, Hendrix A, Hill AF, Lacroix R, Lee Y, van Leeuwen TG, Mackman N, Mäger I, Nolan JP, van der Pol E, Pegtel DM, Sahoo S, Siljander PRM, Sturk G, de Wever O, Nieuwland R.

Circ Res. 2017 May 12;120(10):1632-1648. doi: 10.1161/CIRCRESAHA.117.309417. Review.

PMID:
28495994
47.

Endothelial dysfunction in individuals born after fetal growth restriction: cardiovascular and renal consequences and preventive approaches.

Yzydorczyk C, Armengaud JB, Peyter AC, Chehade H, Cachat F, Juvet C, Siddeek B, Simoncini S, Sabatier F, Dignat-George F, Mitanchez D, Simeoni U.

J Dev Orig Health Dis. 2017 Aug;8(4):448-464. doi: 10.1017/S2040174417000265. Epub 2017 May 2. Review.

PMID:
28460648
48.

Long-term follow-up after autologous adipose-derived stromal vascular fraction injection into fingers in systemic sclerosis patients.

Daumas A, Magalon J, Jouve E, Truillet R, Casanova D, Giraudo L, Veran J, Benyamine A, Dignat-George F, Magalon G, Sabatier F, Granel B.

Curr Res Transl Med. 2017 Jan - Mar;65(1):40-43. doi: 10.1016/j.retram.2016.10.006. Epub 2016 Nov 28.

PMID:
28340695
49.

Increased serum levels of fractalkine and mobilisation of CD34+CD45- endothelial progenitor cells in systemic sclerosis.

Benyamine A, Magalon J, Cointe S, Lacroix R, Arnaud L, Bardin N, Rossi P, Francès Y, Bernard-Guervilly F, Kaplanski G, Harlé JR, Weiller PJ, Berbis P, Braunstein D, Jouve E, Lesavre N, Couranjou F, Dignat-George F, Sabatier F, Paul P, Granel B.

Arthritis Res Ther. 2017 Mar 20;19(1):60. doi: 10.1186/s13075-017-1271-7.

50.

Endothelial Progenitors: A Consensus Statement on Nomenclature.

Medina RJ, Barber CL, Sabatier F, Dignat-George F, Melero-Martin JM, Khosrotehrani K, Ohneda O, Randi AM, Chan JKY, Yamaguchi T, Van Hinsbergh VWM, Yoder MC, Stitt AW.

Stem Cells Transl Med. 2017 May;6(5):1316-1320. doi: 10.1002/sctm.16-0360. Epub 2017 Mar 10. Review.

Supplemental Content

Loading ...
Support Center